The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.

نویسندگان

  • Jean-Charles Lambert
  • Kristel Sleegers
  • Antonio González-Pérez
  • Martin Ingelsson
  • Gary W Beecham
  • Mikko Hiltunen
  • Onofre Combarros
  • Maria J Bullido
  • Nathalie Brouwers
  • Karolien Bettens
  • Claudine Berr
  • Florence Pasquier
  • Florence Richard
  • Steven T Dekosky
  • Didier Hannequin
  • Jonathan L Haines
  • Gloria Tognoni
  • Nathalie Fiévet
  • Jean-François Dartigues
  • Christophe Tzourio
  • Sebastiaan Engelborghs
  • Beatrice Arosio
  • Elicer Coto
  • Peter De Deyn
  • Maria Del Zompo
  • Ignacio Mateo
  • Merce Boada
  • Carmen Antunez
  • Jesus Lopez-Arrieta
  • Jacques Epelbaum
  • Brit-Maren Michaud Schjeide
  • Ana Frank-Garcia
  • Vilmentas Giedraitis
  • Seppo Helisalmi
  • Elisa Porcellini
  • Alberto Pilotto
  • Paola Forti
  • Raffaele Ferri
  • Marc Delepine
  • Diana Zelenika
  • Mark Lathrop
  • Elio Scarpini
  • Gabriele Siciliano
  • Vincenzo Solfrizzi
  • Sandro Sorbi
  • Gianfranco Spalletta
  • Giovanni Ravaglia
  • Fernando Valdivieso
  • Saila Vepsäläinen
  • Victoria Alvarez
  • Paolo Bosco
  • Michelangelo Mancuso
  • Francesco Panza
  • Benedetta Nacmias
  • Paola Bossù
  • Olivier Hanon
  • Paola Piccardi
  • Giorgio Annoni
  • David Mann
  • Philippe Marambaud
  • Davide Seripa
  • Daniela Galimberti
  • Rudolph E Tanzi
  • Lars Bertram
  • Corinne Lendon
  • Lars Lannfelt
  • Federico Licastro
  • Dominique Campion
  • Margaret A Pericak-Vance
  • Hilkka Soininen
  • Christine Van Broeckhoven
  • Annick Alpérovitch
  • Agustin Ruiz
  • M Ilyas Kamboh
  • Philippe Amouyel
چکیده

The only established genetic determinant of non-Mendelian forms of Alzheimer's disease (AD) is the ε4 allele of the apolipoprotein E gene (APOE). Recently, it has been reported that the P86L polymorphism of the calcium homeostasis modulator 1 gene (CALHM1) is associated with the risk of developing AD. In order to independently assess this association, we performed a meta-analysis of 7,873 AD cases and 13,274 controls of Caucasian origin (from a total of 24 centers in Belgium, Finland, France, Italy, Spain, Sweden, the UK, and the USA). Our results indicate that the CALHM1 P86L polymorphism is likely not a genetic determinant of AD but may modulate age of onset by interacting with the effect of the ε4 allele of the APOE gene.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Association of CALHM1 Gene Polymorphism with Late Onset Alzheimer's Disease in Iranian Population

Alzheimer's disease (AD) is a genetically heterogeneous neurodegenerative disease and Late-Onset type (LOAD) is the most common form of dementia affecting people over 65 years old. CALHM1 (P86L) encodes a transmembrane glycoprotein that controls cytosolic Ca(2+) concentrations and Aβ levels and P86L polymorphism in this gene is significantly associated with LOAD in independent case controls in ...

متن کامل

CALHM1 and its polymorphism P86L differentially control Ca2+ homeostasis, mitogen‐activated protein kinase signaling, and cell vulnerability upon exposure to amyloid β

The mutated form of the Ca²⁺channel CALHM1 (Ca²⁺homeostasis modulator 1), P86L-CALHM1, has been correlated with early onset of Alzheimer's disease (AD). P86L-CALHM1 increases production of amyloid beta (Aβ) upon extracellular Ca²⁺removal and its subsequent addback. The aim of this study was to investigate the effect of the overexpression of CALHM1 and P86L-CALHM, upon Aβ treatment, on the follo...

متن کامل

Rare Variants in Calcium Homeostasis Modulator 1 (CALHM1) Found in Early Onset Alzheimer’s Disease Patients Alter Calcium Homeostasis

Calcium signaling in the brain is fundamental to the learning and memory process and there is evidence to suggest that its dysfunction is involved in the pathological pathways underlying Alzheimer's disease (AD). Recently, the calcium hypothesis of AD has received support with the identification of the non-selective Ca(2+)-permeable channel CALHM1. A genetic polymorphism (p. P86L) in CALHM1 red...

متن کامل

A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk

Alzheimer's disease (AD) is a genetically heterogeneous disorder characterized by early hippocampal atrophy and cerebral amyloid-beta (Abeta) peptide deposition. Using TissueInfo to screen for genes preferentially expressed in the hippocampus and located in AD linkage regions, we identified a gene on 10q24.33 that we call CALHM1. We show that CALHM1 encodes a multipass transmembrane glycoprotei...

متن کامل

The role of genetics in alzheimer’s disease

Alzheimer's disease is a progressive neurological disorder that causes the brain to shrink (atrophy) and brain cells die. Alzheimer's disease is the most common cause of dementia and causes a decrease in thinking skills and social behaviors. Alzheimer's disease is more common in people over 65 years old. The risk of developing Alzheimer's disease and other types of dementia increases with age,...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of Alzheimer's disease : JAD

دوره 22 1  شماره 

صفحات  -

تاریخ انتشار 2010